Essay on A Short Note On Diabetes And The Silent Killer

826 Words Nov 26th, 2016 4 Pages
Byvalson Medication Outline
Abstract
Hypertension is known as the silent killer according to the Center for Disease and prevention. Hypertension often presents itself with no warning signs or symptoms and has been related with major cardiovascular (CV) risks, such as stroke and myocardial infarction. According to the National Institute of Statistics about 30 percent of American has hypertension. Poor control of hypertension is a major public health problem in the US, with approximately half of all patients still not achieving target goals (Allergan , 2016).
A pharmaceutical company called Allergen develops a drug called Byvalson that is fixed combination of nebivolol and valsartan. Byvalson is the first and only fixed-dose combination (FDC) of a beta blocker and angiotensin II receptor blocker available in the U.S. Byvalson provides physician and healthcare providers a new fixed dose combination therapy treatment option for patients with hypertension (Allergan , 2016). In this proposal, individuals will learn the indication and usage for this medication, along with its side effects, its interaction, precautions of usage, over dosage, clinical pharmacology, and medication guide.

Byvalson Medication Outline
1. Introduction
1.1) Drug description of Byvalson: it is available as tablets for oral administration. Each tablet contains 5.45 mg of nebivolol hydrochloride, which is equivalent to 5 mg of nebivolol free base, and 80 mg of valsartan.
1.2) Description of the two…

Related Documents